Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

Mostrar otras versiones (1)

BACKGROUND: Hypertension is a prevalent condition among SARS-CoV-2 infected patients. Whether renin–angiotensin–aldosterone system (RAAS) inhibitors are beneficial or harmful is controversial. METHODS: We have performed a national retrospective, nonexperimental comparative study from two tertiary ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Aparisi, Álvaro, Catalá, Pablo, Amat-Santos, Ignacio J., Marcos-Mangas, Marta, López-Otero, Diego, Veras, Carlos, López-Pais, Javier, Cabezón-Villalba, Gonzalo, Cacho Antonio, Carla Eugenia, Candela, Jordi, Antúnez-Muiños, Pablo, Gil, José Francisco, González Ferrero, Teba, Rojas, Gino, Pérez-Poza, Marta, Uribarri, Aitor, Otero-García, Oscar, García-Granja, Pablo Elpidio, Jiménez Ramos, Víctor, Revilla, Ana, Dueñas, Carlos, Gómez, Itzíar, González-Juanatey, José Ramón, San Román, J. Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101788/
https://www.ncbi.nlm.nih.gov/pubmed/34088524
http://dx.doi.org/10.1016/j.medcli.2021.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101788/
https://www.ncbi.nlm.nih.gov/pubmed/34088524
http://dx.doi.org/10.1016/j.medcli.2021.04.005

Ejemplares similares